Downtown-based Steno recently closed a $15 million series B funding round, nearly doubling the company’s total funding to $38.5 million. Leading the way was Brooklyn-based Left Lane Capital, followed ...
An intensive, multifactorial treatment strategy targeting all known modifiable risk factors for vascular damage in patients with type 2 diabetes and microalbuminuria extends life expectancy by a ...
The global legal services industry was worth $849 billion in 2017 and is expected to become a trillion-dollar industry by the end of next year. Little wonder that Steno, an LA-based startup, wants a ...
In the Steno-2 trial, 160 individuals with type 2 diabetes mellitus, mostly in their 50s, were randomly assigned to multifactorial interventions or conventional care. Whereas microvascular and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback